MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3349/ymj.2022.63.5.413

Медицинская библиотека · Yonsei medical journal · 2022

Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium.

Her Ae-Young, Jeong Young-Hoon, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Park Yongwhi, Song Young Bin, Ahn Sung Gyun, Suh Jung-Won, Lee Sang Yeup, Cho Jung Rae, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, PTRG-DES Consortium Investigators

СтатьяОбзорПеревод пока не подготовлен

Аннотация

PURPOSE: Platelet function test (PFT) results and genotype hold unique prognostic implications in East Asian patients. The aim of the PTRG-DES (Platelet function and genoType-Related long-term proGnosis in Drug-Eluting Stent-treated Patients with coronary artery disease) consortium is to assess the clinical impact thereof on long-term clinical outcomes in Korean patients with coronary artery disease during dual antiplatelet therapy (DAPT) including clopidogrel.

MATERIALS AND

METHODS

Searching publications on the PubMed, we reviewed clopidogrel treatment studies with PFT and/or genotype data for potential inclusion in this study. Lead investigators were invited to share PFT/genotype results, patient characteristics, and clinical outcomes to evaluate relationships among them.

RESULTS

Nine registries from 32 academic centers participated in the PTRG-DES consortium, contributing individual patient data from 13160 patients who underwent DES implantation between July 2003 and August 2018. The PTRG-PFT cohort was composed of 11714 patients with available VerifyNow assay results. Platelet reactivity levels reached 218±79 P2Y12 reaction units (PRU), and high on-clopidogrel platelet reactivity based on a consensus-recommended cutoff (PRU >208) was observed in 55.9%. The PTRG-Genotype cohort consisted of 8163 patients with candidate genotypes related with clopidogrel responsiveness. Of those with cytochrome P450 (CYP) 2C19 genotype, frequencies of carrying one and two loss-of-function allele (s) (*2 or *3) were 47.9% (intermediate metabolizers) and 14.2% (poor metabolizers), respectively.

CONCLUSION

The PTRG-DES consortium highlights unique values for on-clopidogrel platelet reactivity and CYP2C19 phenotype that may be important to developing optimal antiplatelet regimens in East Asian patients.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04734028.

Для цитирования: Her Ae-Young, Jeong Young-Hoon, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Park Yongwhi, Song Young Bin, Ahn Sung Gyun, Suh Jung-Won, Lee Sang Yeup, Cho Jung Rae, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, PTRG-DES Consortium Investigators. Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium.. Yonsei medical journal. 2022. DOI: 10.3349/ymj.2022.63.5.413.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.